New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 23, 2013
15:36 EDTCG, JNJCarlyle in lead to buy J&J's Ortho Clinical Diagnostics unit, Reuters says
Carlyle Group in lead to buy J&J's Ortho Clinical Diagnostics unit, Reuters says.
News For CG;JNJ From The Last 14 Days
Check below for free stories on CG;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
08:31 EDTJNJJohnson & Johnson agrees to acquire Alios BioPharma for $1.75B
Subscribe for More Information
08:16 EDTJNJTetraphase price target raised to $32 from $20 at JMP Securities
Subscribe for More Information
07:30 EDTJNJSachs Associates to hold a conference
14th Annual Biotech in Europe Forum for Global Partnering and Investment to be held in Basel, Switzerland on September 30-October 1.
September 26, 2014
11:35 EDTCGCarlyle Group to acquire majority interest in six power plants in Georgia
Carlyle Group announced it has agreed to acquire 75.05% of the outstanding interests and operational control of Southeast PowerGen, a portfolio of six natural gas-fired power plants in Georgia, from ArcLight Capital Partners and GIC, Singapore's sovereign wealth fund. Equity capital for the transaction, terms of which were not disclosed, will come from Carlyle Power Opportunities Capital Partners L.P. and Carlyle Power Partners II L.P. The acquisition increases the size of Carlyle’s power generation portfolio to more than 4,300 MW. Southeast PowerGen, presently owned by a consortium of ArcLight Capital Partners, GIC and GE Energy Financial Services, consists of two natural gas-fired combined-cycle power generation facilities and four natural gas-fired peaking facilities totaling 2,815 MWs.
September 25, 2014
18:05 EDTCGCarlyle Group to pay $115M in collusion suit settlement, Reuters says
Carlyle Group is settling a lawsuit that alleged it colluded with other buyout shops to depress deal prices for $115M, says Reuters. The settlement will be paid through a combination of Carlyle Partners IV fund capital, insurance, balance sheet capital, and contributions from some employees of the firm, added Reuters, citing sources. Reference Link
September 24, 2014
17:59 EDTJNJOdds of Colgate-Palmolive takeover rise amid slew of megamergers, Bloomberg says
Subscribe for More Information
September 23, 2014
13:39 EDTCGGIC in talks with Carlyle over possible GBP 2B takeover of RAC, Sky News says
The Government Investment Corporation of Signapore, or GIC, is in talks with the Carlyle Group over a potential takeover of its RAC division, a roadside assistance company, SkyNews reports, citing a person close to the situation. The deal would be valued at more than GBP 2B, and the deal could occur within days, Sky News added. CVC Capital Patners has also expressed interest in buying the RAC unit from Carlyle. A takeover of RAC would end its prospects of becoming a publicly traded company. The board of RAC will meet in the coming days to decide whether the division should go through with an IPO or pursue a sale of the business, Sky News added, citing an insider. GIC would consider taking a minority stake in RAC before its IPO if it decides to go public, the insider added. Reference Link
08:07 EDTJNJFDA Pediatric Advisory Committee to hold a meeting
Subscribe for More Information
September 22, 2014
08:54 EDTCGCarlyle aims to divest shares in oil-unloading system, WSJ says
Subscribe for More Information
07:50 EDTJNJDoctors continue to use morcellators despite FDA warning, J&J halt, WSJ says
Subscribe for More Information
07:07 EDTJNJSynageva appoints Robert Bazemore as COO
Synageva announced the appointment of Robert Bazemore as Chief Operating Officer. Bazemore will oversee the planned global commercial launch of the company's lead program, sebelipase alfa for LAL Deficiency, and will have responsibility for the company's global commercial, market access and medical affairs operations. Bazemore last served at Johnson & Johnson (JNJ) in varoius roles including Vice President, Ethicon New Growth Platforms and President of Janssen Biotech, a part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
September 17, 2014
08:36 EDTJNJJanssen-Cilag announces results from post-hoc canagliflozin analysis
Subscribe for More Information
08:12 EDTJNJJanssen-Cilag announces results from Phase 3 Invokana trial
Subscribe for More Information
September 16, 2014
07:31 EDTJNJEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use